Endobronchial ultrasound (EBUS) is a minimally invasive highly accurate and safe endoscopic technique for the evaluation of mediastinal lymphadenopathy and mediastinal masses including centrally located lung tumors. The combination of transbronchial and transoesophageal tissue sampling has improved lung cancer staging, reducing the need for more invasive and surgical diagnostic procedures. Despite the high level of evidence regarding EBUS use in the aforementioned situations, there are still challenges and controversial issues such as follows: Should informed consent for EBUS and flexible bronchoscopy be different? Is EBUS able to replace standard bronchoscopy in patients with suspected lung cancer? Which is the best position, screen orientation, route of intubation, and sedation/anesthesia to perform EBUS? Is it advisable to use a balloon in all procedures? How should the operator acquire skills and how should competence be ensured? This Pro-Con article aims to address these open questions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11213616 | PMC |
http://dx.doi.org/10.1097/eus.0000000000000034 | DOI Listing |
Diagn Cytopathol
January 2025
Department of Pathology and Anatomical Sciences, University of Missouri, Columbia, Missouri, USA.
Background: Endobronchial ultrasound guided Transbronchial Needle Aspiration (EBUS-TBNA) is the predominant method for investigation of centrally located solitary pulmonary nodules. The method is associated with good to excellent diagnostic sensitivity and specificity with the positive predictive value of the test reaching 100% and reported negative predictive values for FNA of pulmonary nodules ranging from 53% to 97%. The impact of correlating cytologic results with imaging and clinical findings for improvement of negative predictive value has been poorly studied.
View Article and Find Full Text PDFTuberk Toraks
December 2024
Clinic of Pulmonary Medicine, Liv Vadi İstanbul Hospital, İstanbul, Türkiye.
Tracheal schwannomas are exceedingly rare, accounting for a minute fraction of primary tracheal tumors. They are classified into intraluminal and mixed types, with treatment strategies varying significantly between these subtypes. While thorax tomography is usually sufficient to distinguish intraluminal and mixed type, endobronchial ultrasonography (EBUS) can also be used in cases where the distinction cannot be made clearly with tomography.
View Article and Find Full Text PDFRespir Med Case Rep
November 2024
Department of Pulmonary and Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH, USA.
Ann Thorac Surg Short Rep
December 2024
Division of Thoracic Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Background: Invasive mediastinal staging is a crucial component of the preoperative evaluation for potential surgical candidates with pleural mesothelioma (PM). Endobronchial ultrasound (EBUS) is less invasive than mediastinoscopy for staging; however, its accuracy in patients with PM remains undefined. We present our institutional experience with EBUS staging in patients with PM.
View Article and Find Full Text PDFCureus
November 2024
Department of Radiology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, PAK.
Background Early staging of lung carcinoma (CA) is pivotal in planning the treatment. Lymph node metastasis can be detected by imaging and invasive procedures. The 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) is an emerging noninvasive imaging modality in detecting nodal metastasis.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!